About Borsod-Abauj-Zemplen Megyei Korhaz Es Egyetemi Oktato Korhaz; Onkologiai Osztaly
Clinical Trials at Borsod-Abauj-Zemplen Megyei Korhaz Es Egyetemi Oktato Korhaz; Onkologiai Osztaly
During the past decade, Borsod-Abauj-Zemplen Megyei Korhaz Es Egyetemi Oktato Korhaz; Onkologiai Osztaly conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 3 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Borsod-Abauj-Zemplen Megyei Korhaz Es Egyetemi Oktato Korhaz; Onkologiai Osztaly"
#1 collaborator was "Eisai Inc." with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Borsod-Abauj-Zemplen Megyei Korhaz Es Egyetemi Oktato Korhaz; Onkologiai Osztaly
According to Clinical.Site data, the most researched conditions in "Borsod-Abauj-Zemplen Megyei Korhaz Es Egyetemi Oktato Korhaz; Onkologiai Osztaly" are
"Breast Cancer" (3 trials), "Colorectal Cancer" (2 trials), "Breast Neoplasms" (1 trials), "Carcinoma, Renal Cell" (1 trials) and "Head and Neck Squamous Cell Carcinoma" (1 trials). Many other conditions were trialed in "Borsod-Abauj-Zemplen Megyei Korhaz Es Egyetemi Oktato Korhaz; Onkologiai Osztaly" in a lesser frequency.
Clinical Trials Intervention Types at Borsod-Abauj-Zemplen Megyei Korhaz Es Egyetemi Oktato Korhaz; Onkologiai Osztaly
Most popular intervention types in "Borsod-Abauj-Zemplen Megyei Korhaz Es Egyetemi Oktato Korhaz; Onkologiai Osztaly" are "Drug" (11 trials), "Other" (2 trials), "Biological" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Atezolizumab" (3 trials), "Capecitabine" (3 trials), "Trastuzumab" (3 trials) and "Bevacizumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Borsod-Abauj-Zemplen Megyei Korhaz Es Egyetemi Oktato Korhaz; Onkologiai Osztaly
The vast majority of trials in "Borsod-Abauj-Zemplen Megyei Korhaz Es Egyetemi Oktato Korhaz; Onkologiai Osztaly" are
11 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Borsod-Abauj-Zemplen Megyei Korhaz Es Egyetemi Oktato Korhaz; Onkologiai Osztaly
Currently, there are NaN active trials in "Borsod-Abauj-Zemplen Megyei Korhaz Es Egyetemi Oktato Korhaz; Onkologiai Osztaly".
undefined are not yet recruiting,
1 are recruiting,
6 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Borsod-Abauj-Zemplen Megyei Korhaz Es Egyetemi Oktato Korhaz; Onkologiai Osztaly,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Borsod-Abauj-Zemplen Megyei Korhaz Es Egyetemi Oktato Korhaz; Onkologiai Osztaly, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".